Allogene Therapeutics Inc (ALLO)
2.96
+0.04
(+1.54%)
USD |
NASDAQ |
May 02, 16:00
2.96
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Free Cash Flow: -239.25M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -239.25M |
| September 30, 2023 | -249.15M |
| June 30, 2023 | -241.48M |
| March 31, 2023 | -223.24M |
| December 31, 2022 | -225.71M |
| September 30, 2022 | -208.09M |
| June 30, 2022 | -212.44M |
| March 31, 2022 | -220.61M |
| December 31, 2021 | -206.26M |
| September 30, 2021 | -187.46M |
| June 30, 2021 | -193.08M |
| Date | Value |
|---|---|
| March 31, 2021 | -183.78M |
| December 31, 2020 | -181.05M |
| September 30, 2020 | -218.05M |
| June 30, 2020 | -210.55M |
| March 31, 2020 | -200.52M |
| December 31, 2019 | -188.14M |
| September 30, 2019 | -146.56M |
| June 30, 2019 | -114.74M |
| March 31, 2019 | -88.57M |
| December 31, 2018 | -44.65M |
Free Cash Flow Range, Past 5 Years
-249.15M
Minimum
Sep 2023
-114.74M
Maximum
Jun 2019
-202.64M
Average
-208.09M
Median
Sep 2022
Free Cash Flow Benchmarks
| Agenus Inc | -234.16M |
| ANI Pharmaceuticals Inc | 100.45M |
| Vaxart Inc | -72.32M |
| aTyr Pharma Inc | -37.44M |
| PAVmed Inc | -52.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -53.71M |
| Cash from Investing (Quarterly) | 67.46M |
| Cash from Financing (Quarterly) | 0.155M |
| Free Cash Flow Per Share (Quarterly) | -0.3199 |
| Free Cash Flow to Equity (Quarterly) | -53.89M |
| Free Cash Flow Yield | -51.53% |